Approaching a Paradigm Shift: Redefining Success in Hepatitis B Care
Webinar/Online
Saturday, May 3, 2025 at 6:30pm PT - 8:00pm PT
Add this event to your calendar
Info
Topic
Join us for a live symposium to gain expert insights on the current state of HBV treatment and monitoring, including the shift toward earlier simplified treatment and considerations for quantitative hepatitis B surface antigen monitoring.
Credits Offered
This event offers
1.5 contact hours
to attendees.
Accreditation Info:
ANCC.
Additional Information
Goal Statement
The goal of this program is to improve learners’ knowledge and competence regarding strategies for optimizing current management of people living with chronic hepatitis B, and understanding of progress toward functional cure.
Target Audience
This program is intended for physicians, including gastroenterologists and hepatologists, nurses, pharmacists, and other healthcare professionals involved in the care of people living with chronic hepatitis B.
Learning Objectives
Upon completion of this event, participants should be able to:
- Incorporate expanded and timely treatment for chronic hepatitis B into clinical practice
- Develop optimal monitoring strategies for patients with chronic hepatitis B
- Counsel patients with HBV on the benefits of functional cure
- Describe emerging data on agents targeting a functional cure for HBV
Agenda:
- Realizing the Situation: Burden and Diagnosis of HBV
- Current State: HBV Treatment and Monitoring
- Redefining Success: Breakthroughs in Functional Cure
- Question and Answer Session
Speakers
Section Head, Hepatology, Division of Gastroenterology and Hepatology
Director, Toronto Centre for Liver Disease, University Health Network
Senior Scientist, Toronto General Hospital Research Institute
Francis Family/Dr. Jenny Heathcote Chair in Liver Res
Professor of Medicine
Chief, Division of Gastrointestinal and Liver Disease
Keck School of Medicine
University of Southern California
San Francisco, California
Medical Director, Center for Asian Health & Viral Hepatitis Programs
Cooperman Barnabas Medical Center, RWJ Barnabas-Rutgers Medical Group
Clinical Associate Professor, Rutgers New Jersey Medical School
Senior Advisor of Global Health, Hepatitis B Foundat